A5064349605- Renal cell carcinoma treatment
- Coronary Interventions and Diagnostics
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Maternal and Perinatal Health Interventions
- Bladder and Urothelial Cancer Treatments
- Maternal Mental Health During Pregnancy and Postpartum
- Pregnancy and Medication Impact
- ERP Systems Implementation and Impact
- Acute Myocardial Infarction Research
- Health Systems, Economic Evaluations, Quality of Life
- Cardiac Valve Diseases and Treatments
- Art History and Market Analysis
- Cardiac Imaging and Diagnostics
- Treatment of Major Depression
- Child and Adolescent Psychosocial and Emotional Development
- Artificial Intelligence in Healthcare
- Neuroscience of respiration and sleep
- Extraction and Separation Processes
- Diet and metabolism studies
- Obstructive Sleep Apnea Research
- LGBTQ Health, Identity, and Policy
- Renal and Vascular Pathologies
- Microbial Metabolic Engineering and Bioproduction
- Cancer Genomics and Diagnostics
Cleveland Clinic
2024-2025
University of Alberta
2020-2024
McGill University
2022
Mount Sinai Health System
2020
The University of Queensland
2014-2020
Mount Sinai Beth Israel
2020
Boston College
2016-2017
Massachusetts General Hospital
2010-2013
Harvard University
2005-2013
MedStar Washington Hospital Center
2006
Abstract Objective To examine the safety and efficacy of an extract Tripterygium wilfordii Hook F (TWHF) in treatment patients with rheumatoid arthritis (RA). Methods An ethanol/ethyl acetate from roots TWHF was prepared used a prospective, double‐blind, placebo‐controlled study longstanding RA whom conventional therapy had failed. Patients were randomly assigned to receive either placebo or low‐dose (180 mg/day) high‐dose (360 for 20 weeks, followed by open‐label extension period. Clinical...
We sought to obtain preliminary data regarding the efficacy of omega-3 fatty acids for major depressive disorder associated with menopausal transition. Secondary outcomes were assessed vasomotor symptoms (or hot flashes).After a single-blind placebo lead-in, participants received 8 weeks treatment open-label acid capsules (eicosapentaenoic and docosahexaenoic acid, 2 g/d). The Montgomery-Asberg Depression Rating Scale (MADRS) was primary outcome measure. Hot flashes monitored prospectively...
823 Background: Although Bacillus Calmette-Guérin (BCG) is widely used to treat bladder cancer, its mechanism still not fully understood. Tumor-infiltrating lymphocytes (TIL) have been postulated prognostic value in where presence of TIL signifies favorable outcomes. TILs play an important role the tumor immune microenvironment, mediating response tumorigenesis and immunotherapeutic drugs. Neutrophils are also key players initiation, development progression cancer. This study features...
822 Background: The human microbiome significantly influences the efficacy and safety of various medications. To integrate microbial metabolism into precision medicine, it is crucial to develop strain- molecule-specific computational models that can predict a patient's microbiome's ability metabolize chemotherapy drugs. This study evaluates potential urine, pellet, supernatant samples identify profiles metabolizing genes in patients with bladder cancer. Methods: Catheterized from six (5...
560 Background: In the era of precision medicine, we pursue less invasive, more powerful methods for screening, response prediction, and recurrence detection. While liquid biopsy has proven useful in other malignancies, similar diagnostic prognostic tools renal cell carcinoma (RCC) remain to be elucidated. We therefore aimed investigate serum protein expression patients before their RCC diagnosis vs. non-cancer controls identify protein-cancer associations likely have a role cancer...
BACKGROUND Renal Cell Carcinoma (RCC) is one of the most frequently diagnosed malignancies, yet non-invasive biomarkers for early detection and prognosis in RCC remain scarce. This study aims to identify serum protein markers predictive clear cell (ccRCC) development prognostic survival outcomes. METHODS Using UK Biobank, a prospective cohort >500,000 individuals, we analyzed proteomic data from participants who developed ccRCC after collection (Group 2), those prior 1), controls 3)....